RESCUE OF EMBRYONIC LETHALITY IN MDM2-DEFICIENT MICE BY ABSENCE OF P53

被引:1072
作者
JONES, SN
ROE, AE
DONEHOWER, LA
BRADLEY, A
机构
[1] BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030
[2] BAYLOR COLL MED,DEPT MOLEC VIROL,HOUSTON,TX 77030
关键词
D O I
10.1038/378206a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
THE Mdm2 proto-oncogene was originally identified as one of several genes contained on a mouse double minute chromosome present in a transformed derivative of 3T3 cells(1). Overexpression of Mdm2 can immortalize primary cultures of rodent fibroblasts(2). Human MDM2 is amplified in 30-40% of sarcomas, and is overexpressed in leukaemic cells(3,4). The Mdm2 oncoprotein forms a complex with the p53 tumour-suppressor protein and inhibits p53-mediated transregulation of gene expression(5,6) Because Mdm2 expression increases in response to p53, Mdm2-p53 binding may autoregulate Mdm2 expression and modulate the activity of p53 in the cell(7,8). We have created Mdm2-null and Mdm2/p53-null mice to determine whether Mdm2 possesses developmental functions in addition to the ability to complex with p53, and to investigate the biological role of Mdm2-p53 complex formation in development. Mice deficient for Mdm2 die early in development. In contrast, mice deficient for both Mdm2 and p53 develop normally and are viable. These results suggest that a critical role of Mdm2 in development is the regulation of p53 function.
引用
收藏
页码:206 / 208
页数:3
相关论文
共 23 条
  • [1] BAKER SJ, 1990, SCIENCE, V253, P49
  • [2] BUESORAMOS CE, 1993, BLOOD, V82, P2617
  • [3] MOLECULAR ANALYSIS AND CHROMOSOMAL MAPPING OF AMPLIFIED GENES ISOLATED FROM A TRANSFORMED MOUSE 3T3-CELL LINE
    CAHILLYSNYDER, L
    YANGFENG, T
    FRANCKE, U
    GEORGE, DL
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1987, 13 (03) : 235 - 244
  • [4] INTERACTIONS BETWEEN P53 AND MDM2 IN A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY
    CHEN, CY
    OLINER, JD
    ZHAN, QM
    FORNACE, AJ
    VOGELSTEIN, B
    KASTAN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2684 - 2688
  • [5] CHEN J, 1995, J MOL MED, V1, P142
  • [6] MAPPING OF THE P53 AND MDM-2 INTERACTION DOMAINS
    CHEN, JD
    MARECHAL, V
    LEVINE, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) : 4107 - 4114
  • [7] P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS
    DILLER, L
    KASSEL, J
    NELSON, CE
    GRYKA, MA
    LITWAK, G
    GEBHARDT, M
    BRESSAC, B
    OZTURK, M
    BAKER, SJ
    VOGELSTEIN, B
    FRIEND, SH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) : 5772 - 5781
  • [8] MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS
    DONEHOWER, LA
    HARVEY, M
    SLAGLE, BL
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    [J]. NATURE, 1992, 356 (6366) : 215 - 221
  • [9] THE MDM-2 ONCOGENE CAN OVERCOME WILD-TYPE P53 SUPPRESSION OF TRANSFORMED-CELL GROWTH
    FINLAY, CA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) : 301 - 306
  • [10] JUVEN T, 1993, ONCOGENE, V8, P3411